Medication info

Mg Sulfate Injection 10% (Magnesium Sulfate Hydrate)

Prescription medicationIntramuscular injection · Intravenous injection
Ingredient · strength
Magnesium Sulfate Hydrate›0.1g / 1mL
Manufacturer / importer
(Huons Corporation)
Appearance
Colorless liquid in a colorless ampoule or transparent plastic (polypropylene, polyethylene) container
Packaging
For domestic use - 5 milliliters/ampoule [×20 ampoules], for domestic use - 5 milliliters/ampoule [×25 ampoules], for domestic use - 20 milliliters/ampoule [×50 plastic ampoules], for export - 20 milliliters/ampoule [×20 plastic ampoules], for export - 20 milliliters/ampoule [×40 plastic ampoules]
Approval status
Active

MFDS item code 199903188 · Notified 1999.07.09 · Insurance code 670600671

Summary

Main use
Electrolyte supplementation; suppression of convulsions and seizures (hypomagnesemia, eclampsia); prevention of uterine rigidity
Who receives it
Adults · Children
Adult administration
○ Convulsions due to hypomagnesemia: Inject 1 ∼ 2 g of magnesium sulfate intravenously (4.05 ∼ 8.1 mmol). ○ Eclamptic seizures: Inject 4 ∼ 5 g of this product intravenously over 10 minutes (16.2 ∼ 20.25 mmol) ○ Prevention of uterine rigidity: Inject an initial dose of 4 g of this product intravenously (16.2 mmol). A further 1 g may be administered. ○ Electrolyte replacement (hypomagnesemia): Inject 1 g of this product intramuscularly every 6 hours for 4 doses. Alternatively, 5 g of this product may be added to 5 % glucose injection or 0.9 % normal saline injection and administered intravenously over 3 hours. During treatment of the deficiency, carefully monitor the patient's renal excretory function.
Child administration
○ Pediatrics: The safety of this product has not been studied.

Ingredients

Manufacturer
(Huons Corporation)

Efficacy & effects

Electrolyte supplementation; suppression of convulsions and seizures (hypomagnesemia, eclampsia); prevention of uterine rigidity

  • Seizures due to hypomagnesemia
  • eclampsia seizures
  • uterine contractions
View approved original text

This medication is used to prevent and treat seizures caused by hypomagnesemia. It also helps to alleviate uterine contractions for smoother labor and assists in replenishing electrolytes that may be deficient during hypomagnesemia. Through these benefits, it contributes to improving the patient's symptoms and maintaining health.

How it is given

Adult administration

○ Convulsions due to hypomagnesemia: Inject 1 ∼ 2 g of magnesium sulfate intravenously (4.05 ∼ 8.1 mmol). ○ Eclamptic seizures: Inject 4 ∼ 5 g of this product intravenously over 10 minutes (16.2 ∼ 20.25 mmol) ○ Prevention of uterine rigidity: Inject an initial dose of 4 g of this product intravenously (16.2 mmol). A further 1 g may be administered. ○ Electrolyte replacement (hypomagnesemia): Inject 1 g of this product intramuscularly every 6 hours for 4 doses. Alternatively, 5 g of this product may be added to 5 % glucose injection or 0.9 % normal saline injection and administered intravenously over 3 hours. During treatment of the deficiency, carefully monitor the patient's renal excretory function.

Child administration

○ Pediatrics: The safety of this product has not been studied.

Precautions

This medication is a glass ampoule injection, so great care must be taken when opening the container to avoid the introduction of glass fragments. Extra caution is required when using it for children and the elderly. This medication should not be used in patients with poor kidney function, those in a comatose state, patients with elevated magnesium levels, patients with cardiac conduction disorders, or patients with myasthenia gravis. It should be administered carefully to children with intestinal parasitic infections or patients with heart disease. This medication may cause gastrointestinal symptoms such as vomiting or dry mouth, and rarely cardiac conduction issues or bradycardia may occur. Symptoms of autonomic nervous system involvement, including headache, dizziness, tremors, and tingling, may also appear. In case of overdose, magnesium toxicity can lead to sensations of heat, thirst, low blood pressure, central nervous system depression, suppression of heart rhythm, and respiratory paralysis, requiring immediate treatment with calcium supplements. Caution is advised when used in combination with barbiturates, narcotics, and general anesthetics as they may enhance central nervous system depression. Additionally, taking this medication with iron supplements, certain antibiotics, or sodium fluoride may reduce absorption, so be cautious when taking them together. It can be used in pregnant women for treating eclampsia, but it may affect the fetus with lowered muscle tone, decreased reflexes, and hypotension, so the fetal condition must be closely monitored. During delivery, there is a risk of respiratory depression in the newborn, so it is advisable not to use it within 2 hours after delivery. Long-term use during pregnancy may affect the fetus's bones, requiring careful monitoring of the newborn's calcium and magnesium levels. For lactating women, the safety of this medication has not been established, so it is advisable to avoid use unless absolutely necessary. Elderly individuals may have reduced bodily functions, so it is crucial to administer it slowly and at lower dosages. Serious side effects may occur from overdose, so treatment should be interrupted immediately and, if necessary, detoxification treatment with calcium gluconate injection should be provided. When administered intravenously, the concentration should be reduced to below 10% and infused slowly; it is safest not to mix it with other medications to prevent precipitation. To prevent infection, the injection site and instruments should be thoroughly disinfected, and any remaining solution after opening should not be reused.

Side effects

  • vomiting
  • dry mouth
  • conduction disturbances
  • bradycardia
  • flushing
  • peripheral vasodilation
  • headache
  • feeling of heaviness
  • trembling
  • tingling
Show 7 more
  • sensation of heat
  • thirst
  • hypotension
  • central nervous system suppression
  • heart rate suppression
  • respiratory paralysis
  • warmth at the injection site

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container that prevents air from entering, at temperatures between 1 and 30 degrees Celsius. This will help maintain the medication's efficacy and ensure safe use.

Appearance and packaging

Appearance

Colorless liquid in a colorless ampoule or transparent plastic (polypropylene, polyethylene) container

Package unit

For domestic use - 5 milliliters/ampoule [×20 ampoules], for domestic use - 5 milliliters/ampoule [×25 ampoules], for domestic use - 20 milliliters/ampoule [×50 plastic ampoules], for export - 20 milliliters/ampoule [×20 plastic ampoules], for export - 20 milliliters/ampoule [×40 plastic ampoules]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.